EMA Expired: Sabervel (irbesartan) — Pharmathen S.A.

View source ↗

Summary

The EMA page indicates Sabervel (irbesartan) produced by Pharmathen S.A. has expired status in the European market for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Sabervel (irbesartan)

Snippet

Status: Expired. Therapeutic area: Hypertension. MAH: Pharmathen S.A.. Decision date: 04/09/2014